BSE - Delayed Quote • INR SHIVALIK BIMETAL CONTROLS LTD. (SBCL.BO) Follow Compare 518.10 +6.85 +(1.34%) At close: 3:29:58 PM GMT+5:30 Comparisons Indicators Technicals Corporate Events Line Candle Baseline Mountain Bar Step Baseline Delta HLC Wave Scatterplot Histogram Range Channel Colored Line Colored Mountain Colored Step Colored Bar Colored HLC Volume Candle Hollow Candle Step Mountain Verex Line Vertex Step Vertex Mountain Vertex Baseline Delta Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for SBCL.BO 1D 5D 0.63% 1M -7.63% 3M 0.00% 6M -21.40% YTD -7.63% 1Y -9.06% 5Y 1,452.75% All 71,692.21% Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours 1 day 1 week 1 month 3 months Related News View More All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Apple's China Struggles Weigh on Q1 Results Despite Services Surge Why Tempus AI Inc. (TEM) Soared on Thursday NHS England to offer Casgevy for sickle cell disease patients Exxon Mobil, Chevron See Another Earnings Dip In Q4 But Report Production Increases AbbVie: Q4 Earnings Snapshot AbbVie forecasts 2025 profit above estimates, driven by newer immunology drugs Chevron Earnings Miss Expectations. Why Results Won’t Answer All of Investors’ Questions. These Stocks Are Moving the Most Today: Apple, Intel, Chevron, Walgreens, Visa, Deckers, Atlassian, Vertex, and More Deckers Brands raises full year outlook after strong Q3 FY25 Colgate-Palmolive (NYSE:CL) Misses Q4 Revenue Estimates AbbVie Reports Full-Year and Fourth-Quarter 2024 Financial Results